The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune Diseases

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518797-13-00

Acronym

CNTY-101-151-01

Enrollment

Registered

2025-04-16

Start date

2025-07-10

Completion date

Unknown

Last updated

2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and diffuse cutaneous systemic sclerosis [DcSSc], idiopathic inflammatory myopathy [IIM], systemic lupus erythematosus [SLE]/lupus nephritis [LN]

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026